This just broke into new highs a couple of days ago, so technically it looks good. Seasonally, the sector does very well from May right through until the middle of September. This is the time of year when you want to be in this kind of stock. In the short term, there is the ASCO conference coming up June 2-June 6. This is when a lot of the biotech companies come out with their new products from research. The stock got hammered today, because Pres. Trump called in all the big biotech CEOs, but it turned out they hadn’t talked about pricing at all. So, the weakness today is a buying opportunity.
First Trust Biotechnology Index Fund is a American stock, trading under the symbol FBT-N on the NYSE Arca (FBT). It is usually referred to as AMEX:FBT or FBT-N
In the last year, there was no coverage of First Trust Biotechnology Index Fund published on Stockchase.
First Trust Biotechnology Index Fund was recommended as a Top Pick by on . Read the latest stock experts ratings for First Trust Biotechnology Index Fund.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of First Trust Biotechnology Index Fund published on Stockchase.
On 2025-04-03, First Trust Biotechnology Index Fund (FBT-N) stock closed at a price of $162.0102.
(A Top Pick May 8/17. Up 11.02%.) The period of seasonal strength for this is usually early May right through until the middle of July. We have reached the point where seasonality no longer applies. Now is a good time to take the money off the table.